Hormone analogs including GLP‐1 receptor agonists semaglutide and liraglutide, along with GLP‐1/GIP dual agonists such as tirzepatide, are used clinically to manage metabolic diseases. The gene discussed is GLP1R; the disease is metabolic disease.